PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

You may be eligible if

• Patients have been enrolled in the EAPs
• Patients still alive must provide informed consent if required by local regulations
• Deceased patients are eligible per local regulations, their legal representatives must provide informed consent if required by local regulations